The Operational Weight of Running a Rare-Disease PSP
Rare-disease patient support programs are operationally complex. Each patient intake triggers a cascade of manual steps: verifying insurance eligibility against real-time payer APIs, determining prior authorization requirements, drafting manufacturer copay assistance enrollment letters, and flagging exceptions for free-drug grant review. Specialty pharmacy coordinator teams run these workflows at scale, typically through hub-services CRM platforms and email chains. The cost is real — hub vendor contracts for programs at this scale run $2M–$12M annually — and the headcount model doesn't flex well when patient volumes shift.
How an AI Agent Runs the Intake and Benefits Workflow
An AI Labor Company agent integrates with hub-services CRM call logs and specialty pharmacy coordinator email workflows to learn how your team processes intakes today. From there, it deploys agents to auto-verify insurance eligibility via real-time payer API connections, initiate prior authorization workflows based on payer and formulary logic, and draft manufacturer copay assistance enrollment letters for coordinator review. Exceptions and free-drug grant approvals are flagged for the Patient Services Director to review before fulfillment — your team stays in control of the decisions that require human judgment, while the agent handles the repeatable intake volume.
The Business Case: Faster Access, Lower Vendor Cost
Reducing hub vendor headcount cost by approximately 30% is the direct financial outcome — but the more important driver for many rare-disease programs is speed. An agent that clears the benefits investigation and PA initiation queue faster means patients get to therapy sooner. That matters for adherence, outcomes data, and the program's reputation with prescribers. Workflow efficiency gains on intake and benefits tasks are illustratively in the 55–75% range. Most implementations are live and processing patient intakes within about 8 weeks.
Does the agent handle prior authorization submissions directly to payers?
The agent initiates PA workflows based on payer and formulary logic and prepares the submission documentation. The specific integration with payer portals is scoped during implementation based on your existing hub infrastructure.
How does the agent handle exceptions and free-drug grant decisions?
Exceptions and free-drug grant approvals are flagged for the Patient Services Director to review and approve before fulfillment. The agent handles the routine intake volume; human judgment stays in the loop for high-stakes decisions.
Will this require replacing our current hub vendor infrastructure?
No. The agent integrates with your existing hub-services CRM and coordinator workflows rather than replacing them. It's designed to augment the current stack, not require a platform migration.